Why Quest Diagnostics (DGX) is Chasing the Consumer Testing Market
11/23/2016 6:40:22 AM
Just ask 23andMe, Pathway Genomics, or multiple other genetic testing companies. Each has had its hand slapped by the FDA, which strives to protect the public from accessing raw medical data without expert support.
Quest Diagnostics has not been deterred. The clinical laboratory giant has now launched multiple programs that directly engage today’s informed and empowered customers.
In a recent phone interview, Cathy Doherty, SVP and group executive of clinical franchise solutions said the company’s goal was to be the “provider of choice for consumers.”
comments powered by